Government Affairs
Refine Search
Pharmaceutical
The US Centers for Medicare & Medicaid Services (CMS) has halted movement on several proposals in its Medicare Part D draft rule, many of which had been criticized by the pharma industry (The Pharma Letter February 20) and Congress, as well as patient groups, insurers, pharmacies and health providers. 11 March 2014
Biotechnology
The majority of Members of Parliament in the UK believe there should not be a maximum price per patient for treating people with very rare diseases, according to research commissioned by the trade body the BioIndustry Association (BIA). 11 March 2014
Biotechnology
Trade body France Biotech has outlined its priorities for 2014 with a focus on innovation and removing constraints on its members. 11 March 2014
Generics
Pharmaceutical Research and Manufacturers of America (PhRMA) president and chief executive John Castellani has issued a statement arguing that, while President Obama claims his budget invests in innovation and allows America to compete in the 21st century economy, the reality is that these proposals undermine such efforts. This 2015 budget proposal is damaging to patients, innovation, and the economy, he said. 6 March 2014
Pharmaceutical
South Africa’s National Education, Health and Allied Workers' Union (NEHAWU) has reiterated its position, that the adoption of the National Policy on Intellectual Property is critical in reducing the price of medicines and in improving medication access for the vulnerable in the country’s society. 3 March 2014
Pharmaceutical
Pharmaceutical companies are reducing drug supplies to Greece because of unpaid bills and low profits, according to a report published in The Lancet journal on the impact of the economic crisis on the country’s health care infrastructure. 3 March 2014
Pharmaceutical
The German Bundestag (Parliament) is implementing a number of pharmaceutical policy changes within the scope of the 14th law amending Book V of the German Social Code. 26 February 2014
Pharmaceutical
Brazil’s Congress is considering a proposal on tax exemption on medicines and the house speaker Henrique Eduardo Alves announced that it will create a joint committee to discuss the plans by the end of next week, writes Juliane Carvalho of Brazil Pharma News. 21 February 2014
Pharmaceutical
Pharmaceutical Research and Manufacturers of America (PhRMA) stated yesterday that it is opposed to the proposed rule on Medicare Advantage and Part D that CMS released in early January because it could disrupt care for millions of beneficiaries. 20 February 2014
Pharmaceutical
A Statement of Intent has been jointly signed by officials at India’s Ministry of Health and Family Welfare and US Food and Drug Administration Commissioner Margaret Hamburg, she reported yesterday. 12 February 2014
Pharmaceutical
Belgium’s Deputy Prime Minister Alexander De Croo has put forward the case to make available anonymized medical data stored on 2.5% of the Belgian population, more than 300,000 people, in order to promote “scientific progress” prompting calls for a similar program in the UK. 12 February 2014
Pharmaceutical
A group of Republican Senate and House lawmakers in the USA released statements in response to a report they requested of the Office of the Inspector General (IG) of the Department of Health and Human Services (HHS). 7 February 2014
Pharmaceutical
Medicines Australia has called on the Australian government to save the Pharmaceutical Benefits Scheme (PBS) by delivering stable policies that support the medicines industry and ultimately Australian patients. 6 February 2014
Generics
US Senator Lamar Alexander (Republican, Tennessee), the senior Republican on the Senate Health Committee, is leading a group of Senate and House Republican lawmakers in sending a letter to Food and Drug Administration Commissioner Margaret Hamburg expressing concerns about the FDA’s proposed regulation to allow generic drug companies to unilaterally change their drug labeling information, saying “such a rule would conflict directly with the statute, thwart the law’s purposes and objectives, and impose significant costs on the drug industry and healthcare consumers.” 30 January 2014
Pharmaceutical
The European Parliament's committee on industry, research and energy (ITRE) on January 24 adopted the second public-private joint venture in Innovative Medicines Initiative (IMI2), a partnership of the European Commission and trade group the European Federation of Pharmaceutical Industries and Associations (EFPIA), which has the goal of developing next generation vaccines, medicines and treatments, such as new antibiotics. 28 January 2014
Biotechnology
A review of the UK government's Strategy for UK Life Sciences has found that eight out of the 13 initiatives reviewed have made notable progress towards the actions and commitments set out in the original strategy, but concluded there is still more work to do to meet the strategy's original objectives. 23 January 2014
Pharmaceutical
Pharmaceutical companies and academic researchers will be obliged to upload the results of all their European clinical trials to a publicly accessible database, under draft legislation informally agreed with European Union ministers and approved by Public Health Committee Members of the European Parliament (MEPs) on Wednesday (January 22). 23 January 2014
Pharmaceutical
The UK Parliament heard a second reading of the Intellectual Property Bill in the House of Commons yesterday, following a first reading last August. 21 January 2014
Pharmaceutical
Overlooking concerns about the scarcity of generic drugs in the domestic market given the spate of multinationals acquiring Indian drug majors, the Indian government has decided to continue with the policy of allowing 100% foreign direct investment in existing pharmaceutical firms, comments The Pharma Letter’s Indian correspondent. 20 January 2014
Pharmaceutical
It could be crucially important for growth, exports and employment in Denmark. But not a word was said about the unitary European patent system when Prime Minister Helle Thorning-Schmidt set out the course for 2014 in her New Year's speech, observes the Danish Association of the Pharmaceutical Industry (LIF) in a web posting. 18 January 2014
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze